4//SEC Filing
Yazji Salim 4
Accession 0001209191-23-012402
CIK 0001260990other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:01 PM ET
Size
5.6 KB
Accession
0001209191-23-012402
Insider Transaction Report
Form 4
Yazji Salim
Chief Medical Officer
Transactions
- Award
Stock Option
2023-02-21+210,000→ 210,000 totalExercise: $0.96Exp: 2033-02-21→ Common Stock (210,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest on first anniversary of the date of grant, and the remaining shares subject to the option vest in 36 equal monthly installments, subject to the recipient's continued employment or service with the Issuer on each such date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001864486
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:01 PM ET
- Size
- 5.6 KB